The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
Abstract
Background: Sensitive, specific blood-based tests are difficult to develop unless steps are taken to maximize performance characteristics at every stage of marker discovery and development. We describe a sieving strategy for identifying high-performing marker assays that detect colorectal cancer (CRC)-specific methylated DNA in plasma. Methods: We first used restriction enzyme–based discovery methods to identify marker candidates with obviously different methylation patterns in CRC tissue and nonpathologic tissue. We then used a selection process incorporating microarrays and/or real-time PCR analysis of tissue samples to further test marker candidates for maximum methylation in CRC tissue and minimum amplification in tissues from both healthy individuals and patients with other diseases. Real-time assays of 3 selected markers were validated with plasma samples from 133 CRC patients and 179 healthy control individuals in the same age range. Results: Restriction enzyme–based testing identified 56 candidate markers. This group was reduced to 6 with microarray and real-time PCR testing. Three markers, TMEFF2, NGFR, and SEPT9, were tested with plasma samples. TMEFF2 methylation was detected in 65% [95% confidence interval, 56%–73%] of plasma samples from CRC patients and not detected in 69% (62%–76%) of the controls. The corresponding results for NGFR were 51% (42%–60%) and 84% (77%–89%); for SEPT9, the values were 69% (60%–77%) and 86% (80%–91%). Conclusions: The stringent criteria applied at all steps of the selection and validation process enabled successful identification and ranking of blood-based marker candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
MethyLight: a high-throughput assay to measure DNA methylation
Eads, C. A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.8.e32 · Cited by 1,424
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Baylin, S. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.687 · Cited by 929
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892
Rapid Cycle Real-Time PCR: Methods and Applications
Wittwer, C. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_1 · Cited by 630
Toyota, M., Ho, C., Ahuja, N., Jair, K. W., Li, Q., Ohe-Toyota, M., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 464
CpG-Island Methylation in Aging and Cancer
Issa, J.-P. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_7 · Cited by 300
Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
Toyota, M., Shen, L., Ohe-Toyota, M., Hamilton, S. R., Sinicrope, F. A., & Issa, J. J. (2000) · PubMed · Cited by 191
Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer
Wallner, M., Herbst, A., Behrens, A., Crispin, A., Stieber, P., Göke, B., Lamerz, R., & Kolligs, F. T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1264 · Cited by 183
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
Toyooka, S., Toyooka, K. O., Harada, K., Miyajima, K., Makarla, P., Sathyanarayana, U. G., Yin, J., Sato, F., Shivapurkar, N., Meltzer, S. J., et al. (2002) · PubMed · Cited by 129
DNA Methylation Differences Associated with Tumor Tissues Identified by Genome Scanning Analysis
Liang, G., Salem, C. E., Yu, M. C., Nguyen, H. D., Gonzales, F. A., Nguyen, T. T., Nichols, P. W., & Jones, P. A. (1998) · Genomics · doi:10.1006/geno.1998.5502 · Cited by 114
Quantitative Analysis of Circulating Plasma DNA as a Tumor Marker in Thoracic Malignancies
Herrera, L. J., Raja, S., Gooding, W. E., El‐Hefnawy, T., Kelly, L. A., Luketich, J. D., & Godfrey, T. E. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.039263 · Cited by 111
Hypermethylation of the TPEF/HPP1 Gene in Primary, Metastatic Colorectal Cancers
Ebert, M. P. A., Mooney, S. H., Tonnes–Priddy, L., et al. (2005) · Neoplasia · doi:10.1593/neo.05235 · Cited by 63
Self-citationModel, F., Osborn, N. K., Ahlquist, D. A., Gruetzmann, R., Molnar, B. A., Sípos, F., Galamb, O., Pilarsky, C. P., Saeger, H.-D., Tulassay, Z., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0034 · Cited by 58
Self-citationMultigene Methylation Analysis of Gastrointestinal Tumors
Sabbioni, S., Miotto, E., Veronese, A., Sattin, E., Gramantieri, L., Bolondi, L., Colin, G. A., Gaá, R., Lanza, G., Carli, G., et al. (2003) · Molecular Diagnosis · doi:10.1007/bf03260039 · Cited by 37
DNA Methylation Markers in Patients with Gastrointestinal Cancers
Lofton–Day, C., & Lesche, R. (2003) · Digestive Diseases · doi:10.1159/000075352 · Cited by 25
Self-citationLewin, J., Plum, A., Hildmann, T., Rujan, T., Eckhardt, F., Liebenberg, V., Lofton–Day, C., & Wasserkort, R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.006 · Cited by 23
Self-citation
Cited by
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0230-y · Cited by 813
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Church, T. R., Wandell, M., Lofton-Day, C., Mongin, S. J., Burger, M., Payne, S. R., Castaños-Vélez, E., Blumenstein, B. A., Rösch, T., Osborn, N., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304149 · Cited by 796
Self-citationDNA methylation profiling in the clinic: applications and challenges
Heyn, H., & Esteller, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3270 · Cited by 746
Metadata
- Authors
- Lofton-Day, C., Model, F., DeVos, T., Tetzner, R., Distler, J., Schuster, M., Song, X., Lesche, R., Liebenberg, V., Ebert, M., Molnar, B., Grützmann, R., Pilarsky, C., & Sledziewski, A.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02-01
- Volume
- 54
- Issue
- 2
- Pages
- 414-423
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2115578647
- Cited by
- 493
- References
- 21
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.